MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Inflammation"

  • 2024 International Congress

    TRPV1: A Potential Therapeutic Target for Inflammation and Pain in Parkinson’s Disease

    SJ. Song, YE. Kim (Anyang, Republic of Korea)

    Objective: Unveiling the Pain Mechanism in Parkinson's Disease: A Path to New Therapies Background: Parkinson's disease (PD) are well-known movement disorder. While motor symptoms are…
  • 2024 International Congress

    Functionality Analysis of Immunoregulatory Cells Stimulated with Dopaminergic Agonists in People Living with Parkinson’s Disease

    AY. Regalado-Mustafá, DD. álvarez-Luquín, A. Guevara-Salinas, MA. Bravo-Martinez, EJ. Gallegos-Altamirano, CF. álvarez-Hernández, E. Ichikawa-Escamilla, AM. Peralta-Maza, V. Morales-Ruiz, EE. Sevilla-Reyes, JI. Velasco-Velázquez, JE. Estudillo-Hernández, M. Rodríguez-Violante, LV. Adalid-Peralta (Mexico City, Mexico)

    Objective: To evaluate the effect of dopaminergic agonists (DA) on the activation and functionality of regulatory cells in People living with Parkinson's Disease (PwP). Background:…
  • 2024 International Congress

    The effect of Diabetes Mellitus and Cardiovascular disease on Parkinson’s disease

    T. Abali, SN. Kibrit, Z. özdamar, İ. Köker, AV. Karacan, MK. Yekedüz, R. Yilmaz, FT. Eminoglu, MC. Akbostancı (Ankara, Turkey)

    Objective: To understand the impact of the comorbidities; namely Type 2 Diabetes Mellitus (DM) and/or cardiovascular disease (CVD) on the clinical features of Parkinson’s disease…
  • 2024 International Congress

    Quantification of Neuroinflammation and White Matter Injury in Parkinson Disease Using Diffusion Basis Spectrum Imaging

    R. White Iii, J. Rutlin, B. Maiti, M. Campbell, J. Shimony, J. Perlmutter (Saint Louis, USA)

    Objective: To investigate differences in white matter (WM) using Diffusion Basis Spectrum Imaging (DBSI) between participants with Parkinson’s disease (PD) and controls and to examine…
  • 2024 International Congress

    Reduced intestinal inflammation and increased levels of short-chain fatty acids thanks to an active lifestyle in Parkinson’s disease.

    NES. Chtioui, CHR. Duval, DAV. St-Pierre (Montreal, Canada)

    Objective: This study aimed to determine whether people with Parkinson’s disease (PD) with an active lifestyle had increased production of certain microbial metabolites such as…
  • 2024 International Congress

    Inflammation Biomarkers and Free Water Fraction in the Cholinergic Forebrain System in Idiopathic Parkinson’s Disease

    S. Crowley, P. Kanel, S. Roytman, B. Hampstead, N. Bohnen (Charelston, USA)

    Objective: Investigate if inflammatory biomarkers moderate the association between, cholinergic basal forebrain free water fraction and cholinergic innervation in idiopathic Parkinson’s disease. Background: The cholinergic…
  • 2024 International Congress

    The Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons with REM Sleep Behavior Disorder (RBD)

    J. Cedarbaum, B. Koo, L. Zhang, K. Mead, S. Patel, V. Reddy, D. Hafler (New Haven, USA)

    Objective: To explore the potential for an immunologically based intervention to slow evolution of symptoms in persons with prodromal or Stage 2b (Simuni et al.…
  • 2024 International Congress

    Choreiform Movements Secondary to Sarcoidosis Without Central Nervous System Granulomatosis

    O. Carranza-Renteria, T. Hammond (Boca Raton, USA)

    Objective: To share our experience managing a patient who presented with choreiform movements found to be secondary to sarcoidosis without CNS Granulomatosis. Background: Sarcoidosis is…
  • 2024 International Congress

    The challenge to prevent Parkinson’s Disease with a new in vitro approach

    C. Dalla Verde, S. Gazzin, C. Tiribelli (Trieste, Italy)

    Objective: This research line aims to perform a compound screening on the prophylactic capacity of a high number of nutraceuticals and drugs to prevent dopaminergic…
  • 2024 International Congress

    A Survey of Immunological Mechanisms in Cervical Dystonia

    L. Scorr, G. Kilic-Berkmen, J. Mckay, D. Sutcliffe, A. Mckeon, H. Jinnah (Atlanta, USA)

    Objective: The overall goal was to delineate which aspects of the immune system may be most relevant to the biology of CD. Background: Although several…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 25
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley